Showing results (511-520 of 537) with videos related to
Sort By:
Pageof 54
JACC. Cardiovascular Interventions|October 29, 2025
AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. RegistryRobert Herman, Bryn E Mumma, Jake D Hoyne, et al.JACC. Cardiovascular Interventions|April 24, 2024
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk PatientsNeal S Kleiman, Nicolas M Van Mieghem, Michael J Reardon, et al.Journal of the American College of Cardiology|April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site SelectionWayne B Batchelor, Robert Califf, Roxana Mehran, et al.JACC. Cardiovascular Interventions|August 22, 2015
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal TrialSuzanne V Arnold, Matthew R Reynolds, Kaijun Wang, et al.JAMA Cardiology|November 17, 2021
Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan AreasAshwin S Nathan, Lin Yang, Nancy Yang, et al.Journal of the American College of Cardiology|October 3, 2019
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisSuzanne J Baron, Elizabeth A Magnuson, Michael Lu, et al.Hepatology (Baltimore, Md.)|April 30, 2026
Locoregional lactate dehydrogenase inhibition potentiates therapy and overcomes treatment resistance in hepatocellular carcinomaDaniel J Boehmler, Ryan J Baron, Jennifer A Brain, et al.International Journal of Cardiology|September 13, 2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Shmuel Chen, et al.Circulation|December 28, 2018
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate RiskSuzanne J Baron, Kaijun Wang, John A House, et al.Journal of the American College of Cardiology|November 4, 2017
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL TrialSuzanne J Baron, Khaja Chinnakondepalli, Elizabeth A Magnuson, et al.Pageof 54